SCHEMBL29794145

SCHEMBL29794145

N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCC(N)=O)C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 15/20 0.47
▸ NPY1R P25929 9/20 0.47
▸ NPY5R Q15761 7/20 0.47
▸ NPY2R P49146 5/20 0.47
▸ NOD1 Q9Y239 3/20 0.45
▸ DPP4 P27487 1/20 0.42
▸ DPP8 Q6V1X1 1/20 0.42
▸ DPP9 Q86TI2 1/20 0.42
▸ ALOX15 P16050 1/20 0.41
▸ BLM P54132 1/20 0.41
▸ PMP22 Q01453 1/20 0.41
▸ KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29779796 1.00 NPY4R (0.47) NPY4RNPY1RNPY5RNPY2RNOD1
SCHEMBL9189359 0.97 NOD1 (0.46) NPY4RNPY1RNPY5RNPY2RNOD1
SCHEMBL3753503 0.97 NOD1 (0.46) NPY4RNPY1RNPY5RNPY2RNOD1
SCHEMBL3753495 0.97 NOD1 (0.46) NPY4RNPY1RNPY5RNPY2RNOD1
SCHEMBL29779797 0.96 NPY4R (0.48) NPY4RNPY1RNPY5RNPY2RNOD1
SCHEMBL29887603 0.96 NPY4R (0.48) NPY4RNPY1RNPY5RNPY2RNOD1
SCHEMBL30121059 0.96 NPY4R (0.48) NPY4RNPY1RNPY5RNPY2RNOD1
SCHEMBL30120978 0.96 NPY4R (0.48) NPY4RNPY1RNPY5RNPY2RNOD1
SCHEMBL18660499 0.96 NPY4R (0.48) NPY4RNPY1RNPY5RNPY2RNOD1
SCHEMBL30081096 0.95 NPY4R (0.47) NPY4RNPY1RNPY5RNPY2RNOD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023191148-A1 NOVEL SKIN-PENETRATING PEPTIDE, DERMAL AND MUCOSAL COMPOSITION COMPRISING SAME, AND USE THEREOF 주식회사 셀아이콘랩 2023-10-05 — — WO disclosed
WO-2023191190-A1 TUMOR TISSUE-PENETRATING PEPTIDE, SPECIFICALLY BINDING TO NEUROPILIN 1, FOR DRUG DELIVERY TO TUMOR, AND USE THEREOF 주식회사 셀아이콘랩 2023-10-05 — — WO disclosed
EP-4041748-A1 PEPTIDE COMPOUNDS FOR REDUCING SIDE EFFECTS OF CB1 RECEPTOR AGONISTS Universitat de Barcelona (ES) 2022-08-17 — — EP disclosed
Send feedback